ClinicalTrials.gg
RecruitingNCT07846241VIBEUpdated Sep 30, 2026

Sexual Behavior and Risk Perception as Factors Associated With STI Incidence in Young Adults

An observational study in Sexually Transmitted Infections, sponsored by Parc de Salut Mar. Recruiting at 2 sites in Spain. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Parc de Salut Mar · Observational

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Sexually Transmitted Diseases with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Sexually Transmitted Diseases · Spain.

Started
2026
the only one that year
Observational
6 of 12
3 open now
Registered
12th of 12
by date
Lead sponsor
1 of 12
Parc de Salut Mar

Among the 12 studies in Sexually Transmitted Diseases with a site in Spain, this one is the only one that started in 2026, is one of 6 observational ones, and was the 12th registered.

Sexually Transmitted Diseases

525 studies on the registry are indexed under Sexually Transmitted Diseases; 79 are open to participants now.

Browse Sexually Transmitted Diseases studies →

Open to participants now

4 of the 12 studies in Sexually Transmitted Diseases with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 49 Sexually Transmitted Diseases studies recruiting now, 30 (61%) set no upper age limit and 17 (35%) stop at 75 or younger; 23 take children under 18; 33 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Sexually Transmitted Diseases with a site in Spain, or all of them as a file.
02

Study summary

This observational cross-sectional study aims to assess sexual behavior and perception of sexual risk among young adults aged 18 to 25 years in Barcelona, Spain, and to examine their association with self-reported sexually transmitted infections (STIs). The study will also explore knowledge and beliefs about STIs, protective practices such as condom use, number of sexual partners, and experiences of sexual pressure or coercion. The study will use a validated scale to assess perception of risk related to sexual behavior, together with an additional questionnaire developed for the study population.

Read the detailed description

Sexually transmitted infections (STIs) are an important public health concern among young people. Although young adults may have access to information about STI prevention, this knowledge does not always translate into protective sexual practices.

This observational cross-sectional study will investigate the relationship between sexual behavior, perception of sexual risk, and self-reported STI occurrence among young adults aged 18 to 25 years living in or attending educational institutions in Barcelona, Spain.

Participants will complete an anonymous questionnaire including sociodemographic characteristics, sexual behavior, knowledge and beliefs about STIs, perception of sexual risk, protective practices such as condom use, and number of sexual partners. The questionnaire will also include questions concerning experiences of sexual pressure or coercion and other forms of sexual or digital control. Perception of sexual risk will be assessed using a previously validated scale, complemented by study-specific questions.

The study will describe patterns of sexual behavior and risk perception and will examine whether lower perceived sexual risk is associated with riskier sexual behaviors and a higher prevalence of self-reported STIs.

03

Conditions studied

  • Sexually Transmitted Infections

Keywords

  • Sexual behavior
  • STI risk perception
  • Condom use
  • Young adults
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Young adults aged 18 to 25 years who are recruited in Barcelona, Spain. The study population includes young adults of all sexes and gender identities who are eligible to participate and who voluntarily provide informed consent. Participants will complete an anonymous questionnaire assessing sexual behavior, sexual risk perception, knowledge and beliefs about sexually transmitted infections, preventive practices, and experiences related to sexual pressure or coercion.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 25 years, inclusive.
  • Belonging to the population targeted for recruitment in Barcelona, Spain.
  • Able to understand and complete the study questionnaire.
  • Willing to participate voluntarily and provide .

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years or older than 25 years.
  • Unable to understand or complete the study questionnaire.
  • Declines to provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Sexual risk perception score

    Total score on the validated scale assessing perceived risk associated with sexual behaviors. The score will be used to quantify participants' perception of sexual risk and to examine its association with sexual risk behaviors and self-reported sexually transmitted infections.

    Time frame: At study enrollment

Secondary outcomes

  1. Self-reported diagnosis of a sexually transmitted infection in the past 12 months

    Proportion of participants who report having been diagnosed with a sexually transmitted infection during the previous 12 months, based on the question: "Have you been diagnosed with a sexually transmitted infection in the past 12 months?" Responses will be recorded as yes or no.

    Time frame: At study enrollment

  2. Sexual risk behaviors

    Frequency and prevalence of sexual behaviors associated with increased risk of sexually transmitted infections, assessed by questionnaire, including condom use and other relevant sexual practices.

    Time frame: At study enrollment

  3. Condom use

    Self-reported frequency of condom use during sexual activity, assessed by questionnaire.

    Time frame: At study enrollment

  4. Number of sexual partners

    Self-reported number of sexual partners during the period specified in the study questionnaire.

    Time frame: At study enrollment

Other outcomes

  1. Experiences of sexual pressure or coercion

    Self-reported experiences of sexual pressure, coercion, pressure not to use condoms, psychological violence, or digital control related to sexual relationships during the period specified in the questionnaire.

    Time frame: At study enrollment

  2. Sexual pressure/coercion

    Self-reported experiences of sexual pressure or coercion, including pressure to engage in sexual activity or pressure not to use condoms, as well as psychological or digital control related to sexual relationships, assessed using study-specific questionnaire items.

    Time frame: At study enrollment

  3. Psychological/digital control

    Self-reported experiences of psychological or digital control within sexual or intimate relationships, assessed using study-specific questionnaire items addressing controlling behaviors and digital monitoring or control.

    Time frame: At study enrollment

  4. Sociodemographic variables

    Sociodemographic characteristics of participants, including age, gender identity, educational level, and other demographic variables collected through the study questionnaire. These variables will be used to describe the study population and may be considered as potential confounding or explanatory factors in the analysis.

    Time frame: At study enrollment

07

Study locations

1 of 2 sites recruiting
  • ESIMar - Escola Superior d'Infermeria Hospital del Mar
    Barcelona, 08003, Spain
    Suspended

    Not enrolling at this site.

  • Facultat CC Salut Blanquerna
    Barcelona, 08025, Spain
    Recruiting
08

References and documents

Publications

  • Robles, J. L., Aranda, M., & Montes-Berges, B. (2022). Diseño y validación de la Escala de Percepción del Riesgo para Conducta Sexual en jóvenes ecuatorianos. Suma Psicológica, 29(1), 48-58. https://doi.org/10.14349/sumapsi.2022.v29.n1.5

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2026
First posted
Sep 29, 2026
StartActual
Feb 12, 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Apr 8, 2027
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 2 updates
  1. Sep 30, 2026
    Minor edits only
    + 1 other change: conditions
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07846241
Lead sponsor
Parc de Salut Mar
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Feb 12, 2026
Primary completion
Jan 15, 2027 (estimated)
Completion
Apr 8, 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

Laura García Lausín, PhD
Contact
lgarcialausin@hmar.cat
0034686902138
Ramon Escuriet Peiró, PhD
Contact
rescuriet@gencat.cat
0034606995188
Laura García Lausín, PhD
principal investigator · Hospital del Mar

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion